Guañabens Núria, Mumm Steven, Gifre Laia, Ruiz-Gaspà Silvia, Demertzis Jennifer L, Stolina Marina, Novack Deborah V, Whyte Michael P
Metabolic Bone Diseases Unit, Department of Rheumatology, Hospital Clinic, CIBERehd, IDIBAPS, University of Barcelona, Barcelona, Spain.
Division of Bone and Mineral Diseases, Department of Internal Medicine, Washington University School of Medicine at Barnes-Jewish Hospital, St. Louis, MO, USA.
J Bone Miner Res. 2016 Sep;31(9):1774-82. doi: 10.1002/jbmr.2842. Epub 2016 May 9.
Widely distributed osteosclerosis is an unusual radiographic finding with multiple causes. A 42-year-old premenopausal Spanish woman gradually acquired dense bone diffusely affecting her axial skeleton and focally affecting her proximal long bones. Systemic lupus erythematosus (SLE) diagnosed in adolescence had been well controlled. She had not fractured or received antiresorptive therapy, and she was hepatitis C virus antibody negative. Family members had low bone mass. Lumbar spine bone mineral density (BMD) measured by dual-photon absorptiometry (DPA) at age 17 years, while receiving glucocorticoids, was 79% the average value of age-matched controls. From ages 30 to 37 years, dual-energy X-ray absorptiometry (DXA) BMD Z-scores steadily increased in her lumbar spine from +3.8 to +7.9, and in her femoral neck from -1.4 to -0.7. Serum calcium and phosphorus levels were consistently normal, 25-hydroxyvitamin D (25OHD) <20 ng/mL, and parathyroid hormone (PTH) sometimes slightly increased. Her reduced estimated glomerular filtration rate (eGFR) was 38 to 55 mL/min. Hypocalciuria likely reflected positive mineral balance. During increasing BMD, turnover markers (serum bone-specific alkaline phosphatase [ALP], procollagen type 1 N propeptide [P1NP], osteocalcin [OCN], and carboxy-terminal cross-linking telopeptide of type 1 collagen [CTx], and urinary amino-terminal cross-linking telopeptide of type 1 collagen [NTx and CTx]) were 1.6- to 2.8-fold above the reference limits. Those of bone formation seemed increased more than those of resorption. FGF-23 was slightly elevated, perhaps from kidney disease. Serum osteoprotegerin (OPG) and TGFβ1 levels were normal, but sclerostin (SOST) and receptor activator of nuclear factor kappa-B ligand (RANKL) were elevated. Serum multiplex biomarker profiling confirmed a high level of SOST and RANKL, whereas Dickkopf-1 (DKK-1) seemed low. Matrix metalloproteinases-3 (MMP-3) and -7 (MMP-7) were elevated. Iliac crest biopsy revealed tetracycline labels, no distinction between thick trabeculae and cortical bone, absence of peritrabecular fibrosis, few osteoclasts, and no mastocytosis. Then, for the past 3 years, BMD Z-scores steadily decreased. Skeletal fluorosis, mastocytosis, myelofibrosis, hepatitis C-associated osteosclerosis, multiple myeloma, and aberrant phosphate homeostasis did not explain her osteosclerosis. Mutation analysis of the LRP5, LRP4, SOST, and osteopetrosis genes was negative. Microarray showed no notable copy number variation. Perhaps her osteosclerosis reflected an interval of autoimmune-mediated resistance to SOST and/or RANKL. © 2016 American Society for Bone and Mineral Research.
广泛分布的骨硬化是一种罕见的影像学表现,病因多样。一名42岁的绝经前西班牙女性逐渐出现弥漫性骨密度增高,累及中轴骨骼,并局部累及近端长骨。她在青少年时期被诊断为系统性红斑狼疮(SLE),病情一直控制良好。她未曾发生骨折,也未接受过抗吸收治疗,丙型肝炎病毒抗体检测为阴性。其家庭成员骨量较低。17岁时,她在接受糖皮质激素治疗期间,通过双光子吸收法(DPA)测量的腰椎骨密度(BMD)为年龄匹配对照组平均值的79%。从30岁到37岁,她腰椎的双能X线吸收法(DXA)BMD Z值从+3.8稳步升至+7.9,股骨颈的BMD Z值从-1.4升至-0.7。血清钙和磷水平一直正常,25-羟维生素D(25OHD)<20 ng/mL,甲状旁腺激素(PTH)有时略有升高。她估算的肾小球滤过率(eGFR)降低,为38至55 mL/min。低钙尿症可能反映了矿物质正平衡。在骨密度增加期间,骨转换标志物(血清骨特异性碱性磷酸酶[ALP]、1型前胶原N端前肽[P1NP]、骨钙素[OCN]、1型胶原羧基末端交联肽[CTx]以及尿1型胶原氨基末端交联肽[NTx和CTx])比参考值高出1.6至2.8倍。骨形成标志物的升高似乎比骨吸收标志物更明显。成纤维细胞生长因子23(FGF-23)略有升高,可能与肾脏疾病有关。血清骨保护素(OPG)和转化生长因子β1(TGFβ1)水平正常,但硬化蛋白(SOST)和核因子κB受体活化剂配体(RANKL)升高。血清多重生物标志物分析证实SOST和RANKL水平较高,而Dickkopf-1(DKK-1)似乎较低。基质金属蛋白酶-3(MMP-3)和-7(MMP-7)升高。髂嵴活检显示有四环素标记,厚小梁和皮质骨无差异,无骨小梁周围纤维化,破骨细胞较少,且无肥大细胞增多症。然后,在过去3年中,BMD Z值稳步下降。骨氟中毒、肥大细胞增多症、骨髓纤维化、丙型肝炎相关骨硬化、多发性骨髓瘤以及异常的磷稳态均无法解释她的骨硬化。LRP5、LRP4、SOST和骨石化基因的突变分析均为阴性。基因芯片显示无明显的拷贝数变异。或许她所患的骨硬化反映了自身免疫介导的对SOST和/或RANKL产生抵抗的一个阶段。©2016美国骨与矿物质研究学会